TY  - CONF

T1  - Zoledronic Acid (ZOL) treatment may improve survival in patients with lung cancer and high baseline N-telopeptide levels: a multivariate Cox regression analysis

JO  - EJC SUPPLEMENTS

PY  - 2007/09/01

AU  - Major P

AU  - Hirsh V

AU  - Lipton A

AU  - Cook RJ

AU  - Coleman RE

ED  - 

VL  - 5

IS  - 4

SP  - 94

EP  - 94

Y2  - 2025/10/10

ER  -